Pure Bioscience Files Definitive Proxy Statement
Ticker: PURE · Form: DEF 14A · Filed: Dec 12, 2024 · CIK: 1006028
| Field | Detail |
|---|---|
| Company | Pure Bioscience, Inc. (PURE) |
| Form Type | DEF 14A |
| Filed Date | Dec 12, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, regulatory-filing
TL;DR
PURE BIOSCIENCE FILES PROXY STATEMENT - standard shareholder vote info.
AI Summary
Pure Bioscience, Inc. filed a Definitive Proxy Statement (DEF 14A) on December 12, 2024. This filing is related to the company's proxy materials, which are typically used for shareholder meetings to vote on corporate matters. The company is incorporated in Delaware and its fiscal year ends on July 31.
Why It Matters
This filing is a standard regulatory requirement for public companies, informing shareholders about upcoming meetings and proposals requiring their vote.
Risk Assessment
Risk Level: low — This is a routine regulatory filing and does not inherently present new risks to investors.
Key Players & Entities
- PURE BIOSCIENCE, INC. (company) — Registrant
- 20241212 (date) — Filing Date
- 0001493152-24-049794 (filing_id) — Accession Number
FAQ
What type of filing is this?
This is a Definitive Proxy Statement (DEF 14A).
Who is the registrant?
The registrant is PURE BIOSCIENCE, INC.
When was this filing made?
The filing was made on December 12, 2024.
What is the company's fiscal year end?
The company's fiscal year ends on July 31.
What is the company's state of incorporation?
The company is incorporated in Delaware (DE).
Filing Stats: 4,674 words · 19 min read · ~16 pages · Grade level 13.6 · Accepted 2024-12-12 16:30:34
Filing Documents
- formdef14a.htm (DEF 14A) — 378KB
- formdef14a_001.jpg (GRAPHIC) — 7KB
- formdef14a_002.jpg (GRAPHIC) — 148KB
- formdef14a_003.jpg (GRAPHIC) — 182KB
- 0001493152-24-049794.txt ( ) — 844KB
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 16 DIRECTOR COMPENSATION 21
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 22 SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE 23 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS 23 OTHER MATTERS 24 STOCKHOLDER PROPOSALS FOR 2023 ANNUAL MEETING 24 HOUSEHOLDING OF ANNUAL MEETING MATERIALS 25 ANNUAL REPORT 26 PURE BIOSCIENCE, INC. 771 Jamacha Rd. #512 El Cajon, CA 92019 PROXY TO BE HELD ON JANUARY 22, 2025 GENERAL INFORMATION The accompanying proxy is solicited by the Board of Directors (the “Board” or “Board of Directors”) of PURE Bioscience, Inc. (the “Company”) to be voted at the 2025 Annual Meeting of Stockholders (the “Meeting” or “Annual Meeting”) to be held on Wednesday, January 22, 2025 at SpringHill Suites Huntington Beach Orange County – 7872 Edinger Avenue, Huntington Beach, CA 92647 at 10:30 a.m., local time, and any adjournments or postponements thereof. This “Proxy Statement” and the accompanying proxy are being made available to our stockholders on or about December 12, 2024. References in this Proxy Statement to “the Company,” “we,” “PURE,” “our,” and “us” are to PURE Bioscience, Inc. In accordance with the rules of the Securities and Exchange Commission (the “SEC”), we are permitted to furnish proxy materials, including this Proxy Statement and our Annual Report for the fiscal year ended July 31, 2024 (the “Annual Report”) to stockholders by providing access to these documents through the internet instead of mailing printed copies. Most stockholders will not receive printed copies of the proxy materials unless requested. Instead, our Notice of Internet Availability of Proxy Materials provides instructions on how to access and review the proxy materials on the internet. The Notice of Internet Availability of Prox